Cargando…
Editorial: Establishing Genetic Pleiotropy to Identify Common Pharmacological Agents for Common Diseases
Autores principales: | O’Mara, Tracy A., Batra, Jyotsna, Glubb, Dylan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753863/ https://www.ncbi.nlm.nih.gov/pubmed/31572202 http://dx.doi.org/10.3389/fphar.2019.01038 |
Ejemplares similares
-
Enhancing the Promise of Drug Repositioning through Genetics
por: Pritchard, Jayne-Louise E., et al.
Publicado: (2017) -
The Association of CYP19A1 Variation with Circulating Estradiol and Aromatase Inhibitor Outcome: Can CYP19A1 Variants Be Used to Predict Treatment Efficacy?
por: Glubb, Dylan M., et al.
Publicado: (2017) -
Pleiotropy among Common Genetic Loci Identified for Cardiometabolic Disorders and C-Reactive Protein
por: Ligthart, Symen, et al.
Publicado: (2015) -
10 Years of GWAS discovery in endometrial cancer: Aetiology, function and translation
por: Wang, Xuemin, et al.
Publicado: (2022) -
Dietary Factors and Endometrial Cancer Risk: A Mendelian Randomization Study
por: Wang, Xuemin, et al.
Publicado: (2023)